肝硬化中瘤的隐蔽面:细胞和分子方面
Carlo Airola1,2, Simone Varca1,2, Angelo Del Gaudio1,2
1CEMAD Centro Malattie dell'Apparato Digerente, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Biomedicines
|March 28, 2025
概括
肝硬化中的炎涉及复杂的分子和细胞机制,超出了传统理论. 了解炎症,细胞激活和淋巴失调是开发这种常见并发症的新疗法的关键.
科学领域:
- 肝病学和胃肠道学
- 分子和细胞生物学分子和细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- ,肝硬化的常见并发症,传统上与血液动力学变化和RAAS激活有关.
- 新兴研究揭示了复杂的分子和细胞通路,有助于炎的发病.
研究的目的:
- 审查在阿斯病理生理学中较少探索的分子和细胞机制.
- 突出炎症,细胞激活,淋巴系统和肠道微生物群在炎发展中的作用.
主要方法:
- 文献综述,重点关注的分子和细胞机制.
- 分析炎症,细胞因子,化学因子,ROS和细胞组件 (HSC,SEC,SMC,巨细胞) 之间的相互作用.
主要成果:
- 由细胞因子,化学因子和ROS介导的炎症是关键因素.
- 激活的肝星状细胞,状内皮细胞和光滑肌细胞通过ECM沉积和膜信号传递作出贡献.
- 巨细胞的可塑性,淋巴系统的失调以及肠道微生物群的变化加剧了.
结论:
- 炎的发病是炎症,细胞激活和系统性失调的复杂相互作用.
- 目前的治疗方法并没有专门针对这些新发现的途径.
- 需要进一步的研究,以开发基于这些分子机制的炎向治疗方法.
更多相关视频
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
56.6K
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
2.1K
相关概念视频
Cirrhosis I: Introduction
32
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
32
Cirrhosis II: Pathophysiology
53
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
53
Portal Hypertension
58
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
58
Ascites
54
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
54
Acute Pancreatitis II: Pathophysiology
52
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
52
Chronic Pancreatitis II: Pathophysiology
36
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
36
